A randomized, placebo-controlled clinical trial is underway called VALAD (Valacyclovir Treatment of Alzheimer’s Disease). The protocol was announced in the journal BMJ Open (Feb. 6, 2020).

Antiviral drugs like valacyclovir may help slow or even prevent the disease. Study: Human herpesvirus-associated transposable element activation in human aging brains with Alzheimer's disease.

Jan. 8, 2025 at 6:00 am Updated Jan. 8, 2025 at 7:00 am ...

Valacyclovir (Valtrex) generic is an antiviral agent, prescribed for herpes zoster (shingles), genital herpes and herpes labialis (cold sores). It slows down the growth and spread of the herpes ...

Long-term, low-dose antiviral treatment lowers the risk of vision-damaging inflammation, infection, and pain from shingles affecting the eye, according to new research presented at the annual ...

Participants receiving valacyclovir vs placebo had a significantly lower risk for experiencing subsequent end points (i.e., multiple disease flare-ups; hazard ratios, 0.70 and 0.72 at 12 and 18 ...

ZEDS ran from November 2017 until January 2023, enrolling more than 500 participants who had shingles affecting their eyes. Approximately half received daily doses of valacyclovir for a year, with ...

The valacyclovir dose for cold sores is different from the dose for herpes, and the dose also depends on whether this is your ...

WASHINGTON — Findings from a randomized, double-blind, placebo-controlled trial presented at IDWeek sparked hope for the use of antiviral medications, specifically valacyclovir, for the ...

Conclusions: Experimental treatment with CAN-2409+valacyclovir in NSCLC pts following an inadequate response to ICI is well tolerated and results in the induction of a cytotoxic and memory circulating ...